» Authors » Jim P Buttery

Jim P Buttery

Explore the profile of Jim P Buttery including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 93
Citations 968
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morgan H, Nold M, Kattan G, Vlasenko D, Malhotra A, Boyd J, et al.
Bull World Health Organ . 2025 Mar; 103(3):187-193. PMID: 40026670
Objective: To determine whether hepatitis B virus (HBV) vaccination of extremely preterm infants (defined in our study as < 29 weeks gestation) within 24 hours of birth (birth-dose) increases the...
2.
Clothier H, Parker C, Mallard J, Effler P, Bloomfield L, Carcione D, et al.
Euro Surveill . 2024 Dec; 29(50). PMID: 39668765
IntroductionNuvaxovid became available in Australia from February 2022, a year after the first COVID-19 vaccines. This protein-based vaccine was an alternative for people who had had an adverse event to...
3.
Smith J, Schrader S, Morgan H, Shenton P, Alafaci A, Cox N, et al.
Med J Aust . 2024 Dec; 222(1):23-29. PMID: 39655683
Objectives: To describe myocarditis as an adverse event after coronavirus disease 2019 (COVID-19) vaccination, including a detailed description of clinical phenotypes and diagnostic test results and differences by age, sex,...
4.
Morgan H, Clothier H, Witowski P, Boyd J, Kattan G, Dimaguila G, et al.
Aust N Z J Public Health . 2024 Sep; 48(5):100188. PMID: 39260065
Objective: Post-licensure vaccine safety surveillance of adverse events following immunisation is critical to ensure public safety and confidence in vaccines. This paper aims to describe the governance structure and data...
5.
Nguyen T, Vlasenko D, Shetty A, Reid C, Clothier H, Buttery J
PLoS One . 2024 Jul; 19(7):e0302748. PMID: 38985724
Background: Cardiovascular disease contributes substantially to global mortality and morbidity. Respiratory tract infections, particularly influenza, may trigger an increase in the short-term risk of acute myocardial infarction (AMI) and stroke....
6.
Laemmle-Ruff I, Morgan H, Harris A, Abruzzo V, Clothier H, Osowicki J, et al.
Vaccine . 2024 Jun; 44:126072. PMID: 38890104
No abstract available.
7.
8.
Shetty A, Morgan H, Phuong L, Mallard J, Vlasenko D, Pearce C, et al.
Vaccine . 2024 Feb; 42(8):2011-2017. PMID: 38395721
Introduction: Evidence regarding audiovestibular adverse events post COVID-19 vaccination to date has been inconclusive regarding a potential association. This study aimed to determine if there was an increase in audiovestibular...
9.
Morgan H, Clothier H, Kattan G, Boyd J, Buttery J
Vaccine . 2024 Feb; 42(9):2212-2219. PMID: 38350771
Acute Disseminated Encephalomyelitis (ADEM) and Transverse Myelitis (TM) are within the group of immune mediated disorders of acquired demyelinating syndromes. Both have been described in temporal association following various vaccinations...
10.
Clothier H, Shetty A, Mesfin Y, Mackie M, Pearce C, Buttery J
Vaccine . 2024 Jan; 42(5):1108-1115. PMID: 38262811
Introduction: Understanding background incident rates of adverse events following immunisation (AEFI) is essential to rapidly detect, evaluate, respond to, and communicate about vaccine safety concerns, especially for new vaccines. Creating...